LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

RNase III Nucleases and the Evolution of Antiviral Systems

Photo by nci from unsplash

Every living entity requires the capacity to defend against viruses in some form. From bacteria to plants to arthropods, cells retain the capacity to capture genetic material, process it in… Click to show full abstract

Every living entity requires the capacity to defend against viruses in some form. From bacteria to plants to arthropods, cells retain the capacity to capture genetic material, process it in a variety of ways, and subsequently use it to generate pathogen‐specific small RNAs. These small RNAs can then be used to provide specificity to an otherwise non‐specific nuclease, generating a potent antiviral system. While small RNA‐based defenses in chordates are less utilized, the protein‐based antiviral invention in this phylum appears to have derived from components of the same ancestral small RNA machinery. Based on recent evidence, it would seem that RNase III nucleases have been reiteratively repurposed over billions of years to provide cells with the capacity to recognize and destroy unwanted genetic material. Here we describe an overview of what is known on this subject and provide a model for how these defenses may have evolved.

Keywords: nucleases evolution; capacity; evolution antiviral; antiviral systems; rnase iii; iii nucleases

Journal Title: BioEssays
Year Published: 2018

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.